نتایج جستجو برای: metronomic

تعداد نتایج: 910  

2015
L. MAVROEIDIS H. SHELDON E. BRIASOULIS M. MARSELOS P. PAPPAS A.L. HARRIS

Metronomic chemotherapy is the protracted, dense administration of low sub-toxic doses of chemotherapy, to inhibit tumor angiogenesis. Vinorelbine is an orally bioavailable vinca alkaloid shown to be useable for metronomic administration. In clinical trials, metronomic vinorelbine has been demonstrated to generate sustainable antitumor efficacy at low nanomolar (nM) concentrations with negligib...

2017
Xin-Jun Cai Zeng Wang Jia-Wei Cao Jian-Jun Ni Ying-Ying Xu Jun Yao Hong Xu Fang Liu Gao-Yi Yang

Zoledronic acid (ZOL) has been used as an adjuvant therapy for breast cancer. It is suggested that ZOL might be associated with inhibition of macrophages, which in turn reduces tumor growth, metastasis and tumor angiogenesis. Moreover, metronomic therapy can inhibit tumor angiogenesis and tumor immune cells. Previously we developed ZOL based cationic liposomes that allowed a higher intratumor d...

2014
Gauthier Bouche Nicolas André Shripad Banavali Frank Berthold Alfredo Berruti Guido Bocci Giovanni Brandi Ugo Cavallaro Saviero Cinieri Marco Colleoni Giuseppe Curigliano Teresa Di Desidero Alexandru Eniu Nicola Fazio Robert Kerbel Lisa Hutchinson Urszula Ledzewicz Elisabetta Munzone Eddy Pasquier O Graciela Scharovsky Yuval Shaked Jaroslav Štěrba Martin Villalba Francesco Bertolini

The Fourth Metronomic and Anti-angiogenic Therapy Meeting was held in Milan 24-25 June 2014. The meeting was a true translational meeting where researchers and clinicians shared their results, experiences, and insights in order to continue gathering useful evidence on metronomic approaches. Several speakers emphasised that exact mechanisms of action, best timing, and optimal dosage are still no...

Journal: :Tumori 2011
Elena Collovà Federica Sebastiani Elisabetta De Matteis Daniele Generali Gaetano Aurilio Francesco Boccardo Sergio Crispino Giorgio Cruciani

AIMS AND BACKGROUND Metronomic chemotherapy refers to the administration of low doses of cytotoxic agents over a prolonged period of time with no or only short drug-free intervals. It is designed to overcome acquired tumor resistance to chemotherapy and reduce neo-angiogenesis despite a lower toxicity than with standard chemotherapy. The role of metronomic chemotherapy remains controversial, an...

2016
Bergthor Björnsson Maria Albertsson Per Sandström

Background Metastatic Cholangiocarcinoma is a disease with a dismal prognosis. Treatment options are few, survival short and the side effects of treatments are burdensome. Metronomic chemotherapy can offer tumour regression and palliation. In this study we explore the responses of three patients to this treatment method in cases where conventional chemotherapy treatment has failed. Methods Thre...

Journal: :Molecular cancer therapeutics 2010
Kae Hashimoto Shan Man Ping Xu William Cruz-Munoz Terence Tang Rakesh Kumar Robert S Kerbel

Low-dose metronomic chemotherapy has shown promising activity in many preclinical and some phase II clinical studies involving various tumor types. To evaluate further the potential therapeutic impact of metronomic chemotherapy for ovarian cancer, we developed a preclinical model of advanced human ovarian cancer and tested various low-dose metronomic chemotherapy regimens alone or in concurrent...

2016
Paolo Tralongo Sebastiano Bordonaro Annamaria Di Mari Francesco Cappuccio Sebastiano Rametta Giuliano

BACKGROUND In elderly patients affected by metastatic castration-resistant prostate cancer (mCRPC) chemotherapic treatment may be the choice if one considers not only the chronological age, but also the clinical status, the functional reserve, and the vulnerability of patients. Several studies have confirmed the survival benefit of docetaxel and vinorelbine among every class of age. Most CRP el...

Journal: :Cancer letters 2013
Ke-Wang Luo Chun-Hay Ko Grace G L Yue Michelle Y Y Lee Wing-Sum Siu Julia K M Lee Wai-Ting Shum Kwok-Pui Fung Ping-Chung Leung Gang Li Andreas Evdokiou Clara B S Lau

This study aims to determine the effect of metronomic (0.0125 mg/kg twice a week for 4 weeks) zoledronic acid (ZOL) on cancer propagation and osteolysis against both metastatic and primary breast cancer in mice model. From our results, metronomic ZOL resulted in a significant reduction of tumor burden and did not promote lung or liver metastasis. The metronomic ZOL appeared to be more effective...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Sun Joo Lee Sukhen C Ghosh Hee Dong Han Rebecca L Stone Justin Bottsford-Miller De Yue Shen Edmond J Auzenne Alejandro Lopez-Araujo Chunhua Lu Masato Nishimura Chad V Pecot Behrouz Zand Duangmani Thanapprapasr Nicholas B Jennings Yu Kang Jie Huang Wei Hu Jim Klostergaard Anil K Sood

PURPOSE Most primary human ovarian tumors and peritoneal implants, as well as tumor vascular endothelial cells, express the CD44 family of cell surface proteoglycans, the natural ligand for which is hyaluronic acid. Metronomic dosing, the frequent administration of chemotherapeutics at substantially lower than maximum tolerated doses (MTD), has been shown to result in reduced normal tissue toxi...

2014
Klas Norrby

Metronomic chemotherapy, which is continuously administered systemically at close to non-toxic doses, targets the endothelial cells (ECs) that are proliferating during tumor angiogenesis. This leads to harmful effects of an even greatly increased number contiguous tumor cells. Although pre-clinical studies of angiogenesis-related EC features in vitro and of the anti-angiogenic and anti-tumor ef...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید